Media Room Menu
Month Year
| Su | Mo | Tu | We | Th | Fr | Sa |
|---|---|---|---|---|---|---|
Month Year
| Su | Mo | Tu | We | Th | Fr | Sa |
|---|---|---|---|---|---|---|
-
Mar 4, 2016Praluent is now covered by most health insurance and Medicare plans
-
Feb 12, 2016America's Leading National Consumer Research Survey Ranks ACT Advanced Care #1 in "Oral Care" Category
-
Feb 2, 2016Six researchers each receive $1.625 million in "Pathway to Stop Diabetes®" awards
-
Dec 11, 2015Praluent® is the only PCSK9 inhibitor preferred across UnitedHealth Group formularies, including OptumRx and UnitedHealthcare Commercial, Medicare, and Managed Medicaid formularies
- Dec 1, 2015New 24 and 32-Packs Designed to Manage Dosage Regimens for both Latent and Active Tuberculosis
-
Nov 10, 2015- 74 percent of patients reached their LDL cholesterol goals on 75 mg dose; Of the remaining patients whose dose was adjusted to 150 mg, most achieved their goal -
